Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(17%)
Results Posted
100%(5 trials)

Phase Distribution

Ph phase_3
2
33%
Ph phase_4
3
50%
Ph phase_2
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(5)

Detailed Status

Completed5
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 32 (33.3%)
Phase 43 (50.0%)

Trials by Status

completed583%
recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
completedphase_4

Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron

NCT01950247
recruitingphase_4

Intravenous Iron Effects on Performance at High Altitude

NCT06686693
completedphase_3

Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS

NCT02397057
completedphase_3

Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®

NCT02453334
completedphase_4

Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass

NCT02086968
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01950247Phase 4

Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron

Completed
NCT06686693Phase 4

Intravenous Iron Effects on Performance at High Altitude

Recruiting
NCT02397057Phase 3

Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS

Completed
NCT02453334Phase 3

Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®

Completed
NCT02086968Phase 4

Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass

Completed
NCT02409459Phase 2

Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6